Filing Details

Accession Number:
0000899243-19-027441
Form Type:
4
Zero Holdings:
No
Publication Time:
2019-11-15 20:03:32
Reporting Period:
2019-11-14
Accepted Time:
2019-11-15 20:03:32
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1399529 Dicerna Pharmaceuticals Inc DRNA Pharmaceutical Preparations (2834) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1598480 B James Weissman C/O Dicerna Pharmaceuticals, Inc.
87 Cambridgepark Drive
Cambridge MA 02140
Evp & Chief Operating Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2019-11-14 20,000 $3.42 34,704 No 4 M Direct
Common Stock Disposition 2019-11-14 20,000 $20.00 14,704 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Employee Stock Option (Right to Buy) Disposition 2019-11-14 20,000 $0.00 20,000 $3.42
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
40,000 2023-09-24 No 4 M Direct
Footnotes
  1. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 4, 2018.
  2. This option vested 1/48 monthly on the last day of each month with a vesting start date of 7/30/2013.